The Food and Drug Administration (FDA) is requesting public comments on the National Antimicrobial Resistance Monitoring System (NARMS) 2026-2030 Strategic Plan. The FDA aims to gather input to develop a draft plan, which will be discussed in a public meeting scheduled for spring 2025. They are seeking feedback on how data from NARMS is used, what additional information might be valuable, and suggestions for monitoring antimicrobial resistance within the One Health framework. Comments can be submitted electronically or in writing until March 26, 2025.
Simple Explanation
The FDA wants people to share their ideas to help plan how they will watch for germs that don't respond to medicine from 2026 to 2030. They hope to get ideas on how to make this plan better and will talk more about it in a big meeting in 2025.